These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12537640)

  • 21. Interpretations of primary carcinogenicity data in 29 trichloroethylene risk assessments.
    Rudén C
    Toxicology; 2001 Dec; 169(3):209-25. PubMed ID: 11718961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.
    Caldwell JC; Keshava N; Evans MV
    Environ Mol Mutagen; 2008 Mar; 49(2):142-54. PubMed ID: 17973308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of carcinogenicity of formaldehyde based on the newest literature data].
    Kupczewska-Dobecka M
    Med Pr; 2007; 58(6):527-39. PubMed ID: 18421935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
    Wells MY; Williams ES
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human health effects of trichloroethylene: key findings and scientific issues.
    Chiu WA; Jinot J; Scott CS; Makris SL; Cooper GS; Dzubow RC; Bale AS; Evans MV; Guyton KZ; Keshava N; Lipscomb JC; Barone S; Fox JF; Gwinn MR; Schaum J; Caldwell JC
    Environ Health Perspect; 2013 Mar; 121(3):303-11. PubMed ID: 23249866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trichloroethylene and ocular malformations: analysis of extant literature.
    Williams AL; DeSesso JM
    Int J Toxicol; 2008; 27(1):81-95. PubMed ID: 18293215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.
    Lewandowski TA; Rhomberg LR
    Regul Toxicol Pharmacol; 2005 Feb; 41(1):39-54. PubMed ID: 15649826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARalpha and effects of TCE.
    Klaunig JE; Babich MA; Cook JC; David RM; DeLuca JG; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
    Environ Health Perspect; 2007 Jan; 115(1):A14-5; authohr reply A15-6. PubMed ID: 17366801
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards a harmonized approach for risk assessment of genotoxic carcinogens in the European Union.
    Crebelli R
    Ann Ist Super Sanita; 2006; 42(2):127-31. PubMed ID: 17033132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classifications for carcinogenesis of antitumoral drugs.
    Binetti R; Costamagna FM; Marcello I
    J Exp Clin Cancer Res; 2003 Dec; 22(4):651-72. PubMed ID: 15053312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case-control study on renal cell cancer and occupational exposure to trichloroethylene. Part I: Exposure assessment.
    Fevotte J; Charbotel B; Muller-Beauté P; Martin JL; Hours M; Bergeret A
    Ann Occup Hyg; 2006 Nov; 50(8):765-75. PubMed ID: 16840434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal cell carcinoma and exposure to trichloroethylene: are the French limits of occupational exposure relevant?].
    Charbotel B; Fevotte J; Martin JL; Bergeret A
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):41-7. PubMed ID: 19155150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A search for residual behavioral effects of trichloroethylene (TCE) in rats exposed as young adults.
    Oshiro WM; Krantz QT; Bushnell PJ
    Neurotoxicol Teratol; 2004; 26(2):239-51. PubMed ID: 15019957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukaemia.
    Alexander DD; Mink PJ; Mandel JH; Kelsh MA
    Occup Med (Lond); 2006 Oct; 56(7):485-93. PubMed ID: 16905622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the risk decision process.
    Höfer T
    Toxicology; 2006 May; 222(1-2):154-5; author reply 156-9. PubMed ID: 16487646
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.
    Chiu WA; Okino MS; Evans MV
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):36-60. PubMed ID: 19660485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.